doctor male discussion

Uromedica Wins CMS Coverage for ProAct Continence Therapy Device

Uromedica said today it won a reimbursement code from the Centers for Medicaid and Medicare Services for its ProAct adjustable continence therapy for men, and that it launched the device in the US.  The ProAct system has FDA approval and is indicated for treating adult men with stress incontinence from intrinsic sphincter deficiency of at least 12 months following radical prostatectomy or TURP who have failed ot respond to conservative therapy, the Plymouth, Minn.-based company said. “The issuance of these codes will allow Uromedica to deliver its safe and effective therapy to improve the quality of life for men struggling with Stress Urinary Incontinence,” prez & CEO Tim Cook said in a press release. Read more.

Source: MassDevice Today, July 12, 2017

female athlete running thriathletes

What You Need to Know to Put the Brakes on USI

Urinary stress incontinence (USI) affects 25 per cent of women over 40 with the incidence increasing with age. It’s defined as a loss of urine often with cough, sneeze, laughing, running or lifting. Yet despite the prevalence of this condition, many women do not seek help until symptoms become severe and have been ongoing for at least two years.  Factors contributing to USI are childbirth, pregnancy, menopause, low back pain, weight gain and smoking. USI responds well to conservative non-surgical treatment with the first line of treatment often being pelvic floor strengthening exercises under the supervision of a physiotherapist. Physiotherapists often use biofeedback and electrical stimulation to help reeducate these muscles. Read more.

Source: The Chronicle Herald, February 8, 2017